137 related articles for article (PubMed ID: 7070560)
21. Update in cancer chemotherapy, Part III: Lung cancer, Part 1.
Wright JC
J Natl Med Assoc; 1985 Oct; 77(10):815-27. PubMed ID: 2414458
[TBL] [Abstract][Full Text] [Related]
22. VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas.
Hansen MM; Bloomfield CD; Jørgensen J; Ersbøll J; Pedersen-Bjergaard J; Blom J; Nissen NI
Cancer Treat Rep; 1980; 64(10-11):1135-7. PubMed ID: 7459900
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of lung cancer--state of the art in 2000].
Nakanishi Y; Inoue K; Hara N
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1247-52. PubMed ID: 10945023
[TBL] [Abstract][Full Text] [Related]
24. Doxorubicin and cyclophosphamide chemotherapy for disseminated endometrial cancer.
Seski JC; Edwards CL; Gershenson DM; Copeland LJ
Obstet Gynecol; 1981 Jul; 58(1):88-91. PubMed ID: 7195533
[TBL] [Abstract][Full Text] [Related]
25. Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer.
Leighl NB; Goss GD; Lopez PG; Burkes RL; Dancey JE; Rahim YH; Rudinskas LC; Pouliot JF; Rodgers A; Pond GR; Shepherd FA
Lung Cancer; 2006 Jun; 52(3):327-32. PubMed ID: 16597474
[TBL] [Abstract][Full Text] [Related]
26. Comparison of adriamycin with cyclophosphamide in patients with advanced endometrial cancer.
Horton J; Begg CB; Arseneault J; Bruckner H; Creech R; Hahn RG
Cancer Treat Rep; 1978 Jan; 62(1):159-61. PubMed ID: 626996
[No Abstract] [Full Text] [Related]
27. [Treatment of osteosarcoma: an end to the present impasse?].
Cohen P
Ned Tijdschr Geneeskd; 1976 Nov; 120(45):1932-6. PubMed ID: 1070573
[No Abstract] [Full Text] [Related]
28. Chemotherapy as an adjunct to surgery in the treatment of pulmonary malignant disease.
Mountain CF
Acta Chir Belg; 1971 Apr; 70(4):351-64. PubMed ID: 5143081
[No Abstract] [Full Text] [Related]
29. [Results of chemotherapy of inoperable, non-small-cell bronchial carcinomas].
Fischer M; Mitrou PS
Internist (Berl); 1980 Feb; 21(2):95-107. PubMed ID: 6154667
[No Abstract] [Full Text] [Related]
30. ICRF-159 versus polychemotherapy in non-small cell lung cancer.
Eagan RT; Carr DT; Coles DT; Rubin J; Frytak S
Cancer Treat Rep; 1976 Jul; 60(7):947-8. PubMed ID: 64297
[No Abstract] [Full Text] [Related]
31. [Chemotherapy of small cell lung cancer].
Komiya T; Takada M
Gan To Kagaku Ryoho; 1996 Aug; 23(9):1116-23. PubMed ID: 8751797
[TBL] [Abstract][Full Text] [Related]
32. [Therapy of the small cell bronchial carcinoma].
Bruntsch U
MMW Munch Med Wochenschr; 1980 Sep; 122(37):1248-52. PubMed ID: 6775205
[No Abstract] [Full Text] [Related]
33. Treatment of unresectable nonsmall-cell lung cancer (NSCLC).
Papacharalambous A; Rigatos G; Alexopoulos A; Stavrakakis J; Scartsilas C; Stavrinidis E
J Chemother; 1989 Jul; 1(4 Suppl):1214-5. PubMed ID: 16312839
[No Abstract] [Full Text] [Related]
34. Phase II trial of 5-fluorouracil (NSC-19893), adriamycin (NSC-123127), and methotrexate (NSC-740) in lung adenocarcinoma.
Lowitz BB
Cancer Treat Rep; 1976 May; 60(5):623-4. PubMed ID: 991153
[No Abstract] [Full Text] [Related]
35. Enhanced pulmonary toxicity with bleomycin and radiotherapy in oat cell lung cancer.
Einhorn L; Krause M; Hornback N; Furnas B
Cancer; 1976 May; 37(5):2414-6. PubMed ID: 56987
[TBL] [Abstract][Full Text] [Related]
36. Combination chemotherapy for bronchogenic carcinoma with doxorubicin, BCNU, and cyclophosphamide (ABC): a pilot study of the Southeastern Cancer Study Group.
Denes AE; Presant CA; Bartolucci A
Cancer Treat Rep; 1982 Jan; 66(1):199-200. PubMed ID: 7053258
[No Abstract] [Full Text] [Related]
37. Hypercalcemia in cancer: response to therapy.
Tashima CK
Am Fam Physician; 1974 Nov; 10(5):156-9. PubMed ID: 4278933
[No Abstract] [Full Text] [Related]
38. [Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer or head and neck cancer].
Plasswilm L
Strahlenther Onkol; 2000 Dec; 176(12):583-4. PubMed ID: 11140154
[No Abstract] [Full Text] [Related]
39. Failure of intensive combination therapy (cyclophosphamide, adriamycin, 5-fluorouracil) to control adenocarcinoma or large-cell anaplastic carcinoma of lung.
Taylor RE; Smith IE; Ford HT; Bryant BM; Casey AJ; Smyth JF
Cancer Chemother Pharmacol; 1980; 4(4):271-3. PubMed ID: 6254685
[TBL] [Abstract][Full Text] [Related]
40. A phase II multicenter trial of high-dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for patients with high-risk non-Hodgkin's lymphoma.
Schenkein DP; Roitman D; Miller KB; Morelli J; Stadtmauer E; Pecora AL; Cassileth P; Fernandez H; Cooper BW; Kutteh L; Lazarus HM
Biol Blood Marrow Transplant; 1997 Oct; 3(4):210-6. PubMed ID: 9360783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
